www.fdanews.com/articles/176515-flamel-technologies-akovaz-scoops-up-fda-approval
Flamel Technologies has secured FDA approval for its surgical hypotension drug Akovaz.
The company said it will launch the injectable drug at a 50 mg/mL dosage at some point in the third quarter. Flamel is the first company to receive FDA approval for this formulation of the drug.